This is a $1,844.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,943,120 units of 1,000 mg/10 ml procainamide vials. The contract has an ultimate completion date of June 20, 2024 and was awarded on June 18, 2024. This delivery order is under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,377.45, is for the delivery of 4,564,389,989 units of Procainamide 1 gram/10 ml vials. The contract is a firm fixed-price agreement with an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that supplies a wide range of medical products and...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $2,269.62 contract is for the delivery of 4,564,138,129 units of Procainamide 1,000 mg/2 ml vials to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,959.60 firm-fixed-price contract is for the supply of Procainamide 1 gram/10 ml vials, a medication used to treat certain heart rhythm disorders. The contract has an ultimate completion date of May 17, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565964779 - Procainamide 1 Gram/10 ML Vial 10ML. The contract has a ceiling value of $1,377.45 and a period of performance through September 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the provision of 4,564,731,048 units of the pharmaceutical product Procainamide 1,000 mg/2 ml at a firm fixed price of $3,440.89. The contract has an ultimate completion date of May 29, 2024 and does not include a set-aside designation. AmerisourceBergen Drug Corp, a subsidiary of the major pharmaceutical distribution company AmerisourceBergen Corporation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Procainamide 1 gram/10 ml vials, a medication used in the treatment of certain heart rhythm disorders. The contract has a ceiling value of $6,660.76 and a period of performance through January 7, 2025. The contract is a firm fixed-price delivery order and does...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,434.44 firm fixed-price contract is for the delivery of the pharmaceutical product Procainamide 1 Gram/10 ML Vial 10ML, to support military healthcare programs. The contract has an ultimate completion date of November 25, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourceberger Drug Corp, a for-profit pharmaceutical distribution company, to provide 4,563,782,502 units of Procainamide 1 gram/10 ml vials. The contract has a completion date of February 28, 2024 and a potential value of $1,399.16. This award is part of Amerisourceberger's existing indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, to...
This is a delivery order awarded by the Medical Supply Chain division of the U.S. Department of Defense to Amerisourcebergen Drug Corp's Corporate Office division. The $2,864.60 firm fixed price contract is for the delivery of 4,561,510,267 units of Procainamide 1 gram/10 ml vial, a pharmaceutical product used to treat certain heart rhythm disorders. The contract has an ultimate completion date of July 18, 2023 and was awarded on July 17, 2023. This order is part of a larger Indefinite...